Quality Control

Discussion on polymorph consistency evaluation for cefotaxime sodium for injection*

Expand
  • National Institutes for Food and Drug Control, Beijing 102629, China

Received date: 2021-03-18

  Online published: 2024-06-21

Abstract

Objective: To provide recommendations for crystal form consistency evaluation of cephalosporin injections by comparing the crystal form of cefotaxime sodium between its generic raw material or preparation and refe-rence medical product by several popular polymorph methods. Methods: According to the physical and chemical properties of cefotaxime sodium, methods including powder X-ray diffraction(CuKα radiation: λ=1.541 862 Å; voltage: 45 kV; current: 200 mA; scan scope: 3-60 °), thermal analysis(scan scope: 30-400 ℃; heating rate: 10 ℃·min-1), Raman mapping(excitation wavelength: 785 nm; mapping scope: 1 mm×1 mm) and scanning electron microscope(voltage: 5.0 kV; magnification: ×400~×1 200; detector: secondary electron), were selected to evaluate crystalline characteristics. Results: The crystal structure of all the generic batches was basically the same as that of reference preparation, and their characteristic temperatures of desolvation (77 ℃) and thermal decomposition (208 ℃) were close to each other. However, only reference preparation had a volatilization peak of low boiling solvent near 54 ℃ in the thermogravimetric line, and contained a small amount of variant crystals. The crystals of generic batches were flaky with small particle size (several microns), while those of reference preparation were spherical with large particle size (close to 100 μm). Conclusion: The evaluation of crystal form consistency for cephalosporin injections can be comprehensively characterized by the above methods, obtaining the crystal structure, the situation of crystallized water and solvent, polymorphic phenomenon, and the difference of crystal habit.

Cite this article

QI Shu-ye, ZOU Wen-bo, YAO Shang-chen, XU Ming-zhe, YIN Li-hui . Discussion on polymorph consistency evaluation for cefotaxime sodium for injection*[J]. Chinese Journal of Pharmaceutical Analysis, 2021 , 41(10) : 1836 -1843 . DOI: 10.16155/j.0254-1793.2021.10.22

References

[1] 胡昌勤. 对抗生素注射剂一致性评价/再评价的思考[J].中国抗生素杂志, 2019, 44(3): 281
HU CQ. Rethought on quality consistency evaluation/re-evaluation for domestic antibiotic injections[J].Chin J Antibiot, 2019, 44(3): 281
[2] 张斗胜, 薛晶, 王晨, 等. 注射用头孢菌素的关键质量属性分析[J].中国新药杂志, 2016, 25(22): 2606
ZHANG DS, XUE J, WANG C, et al. Critical quality attributes of cephalosporins for injection[J].Chin J New Drugs, 2016, 25(22): 2606
[3] 陈辉, 陈立宗, 丁尚志, 等. 反应结晶制备头孢菌素类抗生素研究进展[J].山东化工, 2020, 49(10): 83
CHEN H, CHEN LZ, DING SZ, et al. Research progress of reaction crystallization to prepare cephalosporin antibiotics[J].Shangdong Chem Ind, 2020, 49(10): 83
[4] 张淑华, 袁靖, 欧真容, 等. 注射用头孢噻肟钠等6种头孢菌素的体外抗菌活性研究[J].中国抗生素杂志, 2004, 29(6): 357
ZHANG SH, YUAN J, OU ZR, et al. The in vitro antibacterial activity against clinical isolates of six cephalosporins for injection[J].Chin J Antibiot, 2004, 29(6): 357
[5] 中华人民共和国药典2020年版. 二部[S]. 2020: 360
ChP 2020. Vol Ⅱ[S]. 2020: 360
[6] DE ARMAS HN, PARDILLO-FONTDEVILA E, HERNÁNDEZ RP. Crystal and X-ray powder diffraction data for cefotaxime sodium salt, C16H16N5NaO7S2[J].Powder Diffr, 1999, 14(2): 142
[7] 杨世颖, 周健, 张丽, 等.我国化学药物晶型研究现状与进展[J].医药导报, 2019, 38(2): 177
YANG SY, ZHOU J, ZHANG L, et al. Present situation and progress of the research for polymorphic chemical drugs in China[J].Her Med, 2019, 38(2): 177
[8] 国家药监局关于发布仿制药参比制剂目录(第二十三批)的通告(2020年第4号)[EB/OL](2020-01-03)[2020-01-07].https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/2020010 7161001838.html
Circular of the State Drug Administration on Issuing the Catalogue of Generic Reference Preparations (the 23rd Batch) (No.4 in 2020)[EB/OL].(2020-01-03)[2020-01-07]. https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20200107161001838.html
[9] 中华人民共和国药典2020年版.四部[S].2020: 55
ChP 2020. Vol Ⅳ [S]. 2020: 55
[10] 张海涛. 头孢噻肟钠结晶技术研究[D]. 天津: 天津大学, 2008
ZHANG HT. Research on Crystallization Technique of Cefotaxime Sodium[D]. Tianjin: Tianjin University, 2008
[11] 孙宽. 热分析技术在药品检验与研究中的应用[J].临床医药文献电子杂志, 2020, 7(44): 178
SUN K. Application of thermal analysis technology in pharmaceutical analysis[J].J Clin Med Lit (Electron Ed), 2020, 7(44): 178
[12] 王艳色, 魏志勇, 申凯华, 等. 调制差示扫描量热法在高分子材料中的应用[J].高分子通报, 2016(3): 16
WANG YS, WEI ZY, SHEN KH, et al. Application of modulated differential scanning calorimetry in polymer research[J].Chin Polym Bull, 2016(3): 16
[13] 张正行. 有机光谱分析[M]. 北京: 人民卫生出版社, 2009: 55
ZHANG ZX. Organic Spectroscopy Analysis[M]. Beijing: People’s Medical Publishing House, 2009: 55
[14] 天津大学. 一种制备头孢噻肟钠晶体的方法: 中国, 201510264083.X[P].2015-09-09
Tianjin University. A Method for Preparation of Cefotaxime Sodium Crystals: China, 201510264083.X[P]. 2015-09-09
[15] SOHN YT, KIM HK. Dissolution of crystal forms of cefotaxime sodium[J].J Kor Pharm Sci, 1998, 28(2): 81
[16] 王海洋, 杜艳妮, 李振方, 等. 硫酸氢氯吡格雷球形结晶工艺及其生长机理[J].化工学报, 2015, 66(9): 3633
WANG HY, DU YN, LI ZF, et al. Crystallization process and growth mechanism for spherical products of clopidogrel sulfate[J].CIESC J, 2015, 66(9): 3633
Outlines

/